| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 124629-88-5 | syringomycin A1 (9CI); 1-Oxa-4,7,10,13,16,19,22,25-octaazacyclooctacosane,cyclic peptide deriv.; (R)-N-(3-Hydroxy-1-oxodecyl)-L-seryl-D-seryl-L-2,4-diaminobutanoyl-D-2,4-diaminobutanoyl-L-arginyl-L-phenylalanyl-(Z)-2,3-didehydro-2-aminobutanoyl-threo-3-hydroxy-L-a-aspartyl-4-chloro-L-threonine b1-lactone; L-Threonine,N-(3-hydroxy-1-oxodecyl)-L-seryl-D-seryl-L-2,4-diaminobutanoyl-D-2,4-diaminobutanoyl-L-arginyl-L-phenylalanyl-(Z)-2,3-didehydro-2-aminobutanoyl-threo-3-hydroxy-L-a-aspartyl-4-chloro-, b1-lactone, (R)- |  | C51H81ClN14O17 | 詳情 | 供應商 | |
| 124888-22-8 | syringomycin E (9CI); syringomycinA1, 1-[N-(3-hydroxy-1-oxododecyl)-L-serine]-, (R)-; 1-Oxa-4,7,10,13,16,19,22,25-octaazacyclooctacosane, cyclic peptide deriv.; L-Threonine,N-(3-hydroxy-1-oxododecyl)-L-seryl-D-seryl-L-2,4-diaminobutanoyl-D-2,4-diaminobutanoyl-L-arginyl-L-phenylalanyl-(Z)-2,3-didehydro-2-aminobutanoyl-threo-3-hydroxy-L-a-aspartyl-4-chloro-, b1-lactone, (R)- |  | C53H85ClN14O17 | 詳情 | 供應商 | |
| 129431-15-8 | syringomycin E (9CI); syringomycinA1, 1-[N-(3-hydroxy-1-oxododecyl)-L-serine]-, (R)-; 1-Oxa-4,7,10,13,16,19,22,25-octaazacyclooctacosane, cyclic peptide deriv.; L-Threonine,N-(3-hydroxy-1-oxododecyl)-L-seryl-D-seryl-L-2,4-diaminobutanoyl-D-2,4-diaminobutanoyl-L-arginyl-L-phenylalanyl-(Z)-2,3-didehydro-2-aminobutanoyl-threo-3-hydroxy-L-a-aspartyl-4-chloro-, b1-lactone, (R)- |  | C53H85ClN14O17 | 詳情 | 供應商 | |
| 124888-23-9 | syringomycin G (9CI); syringomycinA1, 1-[N-(3-hydroxy-1-oxotetradecyl)-L-serine]-, (R)-; 1-Oxa-5,8,11,14,17,20,23,26-octaazacyclononacosane, cyclic peptide deriv.; L-Threonine,N-(3-hydroxy-1-oxotetradecyl)-L-seryl-D-seryl-L-2,4-diaminobutanoyl-D-2,4-diaminobutanoyl-L-arginyl-L-phenylalanyl-(Z)-2,3-didehydro-2-aminobutanoyl-threo-3-hydroxy-L-a-aspartyl-4-chloro-, b1-lactone, (R)- |  | C55H89ClN14O17 | 詳情 | 供應商 |